vaccine

June 15, 2017

Schaffner receives UpShot Award in vaccine communication

The National Vaccine Program Office in the U.S. Department of Health and Human Services has selected William Schaffner, M.D., to receive its 2017 NVPO UpShot Award in Vaccine Communication.

By Craig Boerner
January 25, 2017

Flu vaccine response in older adults

High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells.

By Leigh MacMillan
January 20, 2017

Improving vaccine formulations

The compound MPLA is an attractive vaccine component, designed to elicit a robust immune response.

By Sanjay Mishra
flu shot
August 13, 2014

High-dose flu vaccine more effective in elderly, Vanderbilt-led study shows

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.

By Craig Boerner
May 27, 2014

Respiratory virus vaccine candidate

Virus-like particles containing a protein from human metapneumovirus are a promising vaccine candidate for this respiratory virus.

By Leigh MacMillan
May 1, 2014

Cutting-edge research to be showcased in May

By Bill Snyder
April 7, 2014

Vanderbilt Vaccine Center joins global task force to address urgent viral threat

By John Howser
January 15, 2014

HIV’s impact on B cells

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.
By Leigh MacMillan
August 15, 2013

Flulapalooza vaccination event set for Sept. 25

Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that two years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period.
By Nancy Humphrey
May 30, 2013

Study lays groundwork for rational T cell vaccine design

Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response.
By Leigh MacMillan
November 12, 2012

UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses

Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals.
By VUMC News and Communications
October 31, 2012

Protein’s length, flexibility key to infection

The structural architecture of the reovirus attachment protein is required for efficient reovirus infection of host cells.
By Leigh MacMillan
October 10, 2012

Additional volunteers needed for Flulapalooza Oct. 17 and 18

By Nancy Humphrey
1 2 3